260 related articles for article (PubMed ID: 24215335)
1. The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model.
Ozgonul C; Mumcuoglu T; Gunal A
Curr Eye Res; 2014 May; 39(5):451-9. PubMed ID: 24215335
[TBL] [Abstract][Full Text] [Related]
2. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit.
Memarzadeh F; Varma R; Lin LT; Parikh JG; Dustin L; Alcaraz A; Eliott D
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3233-7. PubMed ID: 19182254
[TBL] [Abstract][Full Text] [Related]
3. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study.
Chua BE; Nguyen DQ; Qin Q; Ruddle JB; Wells AP; Niyadurupola N; Gupta V; Wong TT; Coote MA; Crowston JG
Clin Exp Ophthalmol; 2012 Nov; 40(8):773-9. PubMed ID: 22429268
[TBL] [Abstract][Full Text] [Related]
4. Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs.
Simsek T; Cankaya AB; Elgin U
J Ocul Pharmacol Ther; 2012 Oct; 28(5):542-6. PubMed ID: 22731246
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study.
Grewal DS; Jain R; Kumar H; Grewal SP
Ophthalmology; 2008 Dec; 115(12):2141-2145.e2. PubMed ID: 18692246
[TBL] [Abstract][Full Text] [Related]
6. Delayed post-operative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Zuppardi E; Lobefalo L; Gallenga PE
Eye (Lond); 1998; 12 ( Pt 4)():701-6. PubMed ID: 9850268
[TBL] [Abstract][Full Text] [Related]
7. CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
Ma J; Li X; Zhang W; Huang L; Chen M; Xi L; Zhang Z; Duan L; Quan D; Ge J
Curr Eye Res; 2014 Oct; 39(10):982-8. PubMed ID: 24787678
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery.
How A; Chua JL; Charlton A; Su R; Lim M; Kumar RS; Crowston JG; Wong TT
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):928-32. PubMed ID: 19797222
[TBL] [Abstract][Full Text] [Related]
9. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy.
Rodríguez-Agirretxe I; Vega SC; Rezola R; Vecino E; Mendicute J; Suarez-Cortes T; Acera A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5227-35. PubMed ID: 23800769
[TBL] [Abstract][Full Text] [Related]
10. α5β1-Integrin inhibitor (CLT-28643) effective in rabbit trabeculectomy model.
Schultheiss M; Schnichels S; Konrad EM; Bartz-Schmidt KU; Zahn G; Caldirola P; Fsadni MG; Caram-Lelham N; Spitzer MS
Acta Ophthalmol; 2017 Feb; 95(1):e1-e9. PubMed ID: 27576860
[TBL] [Abstract][Full Text] [Related]
11. Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs.
Tai TY; Moster MR; Pro MJ; Myers JS; Katz LJ
J Glaucoma; 2015; 24(4):311-5. PubMed ID: 25826644
[TBL] [Abstract][Full Text] [Related]
12. Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery.
Ferreira Jde L; Chahud F; Ramalho LN; Modulo CM; Vieira LC; Reinach PS; Rodrigues Mde L; Cunha AS; Paula JS
Curr Eye Res; 2015; 40(11):1134-40. PubMed ID: 25494917
[TBL] [Abstract][Full Text] [Related]
13. The effect of bevacizumab on the outcome of trabeculectomy with 5-Fluorouracil.
Suh W; Kee C
J Ocul Pharmacol Ther; 2013 Sep; 29(7):646-51. PubMed ID: 23621628
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
Sengupta S; Venkatesh R; Ravindran RD
J Glaucoma; 2012 Sep; 21(7):450-9. PubMed ID: 21543993
[TBL] [Abstract][Full Text] [Related]
15. Impact of trastuzumab on wound healing in experimental glaucoma surgery.
Turgut B; Eren K; Akin MM; Bilir Can N; Demir T
Clin Exp Ophthalmol; 2015; 43(1):67-76. PubMed ID: 24801440
[TBL] [Abstract][Full Text] [Related]
16. Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.
Martorana GM; Schaefer JL; Levine MA; Lukowski ZL; Min J; Meyers CA; Schultz GS; Sherwood MB
PLoS One; 2015; 10(9):e0138054. PubMed ID: 26394037
[TBL] [Abstract][Full Text] [Related]
17. Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits.
Lu DW; Chang CJ; Chiang CH; Yeh MK; Chou PI
J Ocul Pharmacol Ther; 2000 Dec; 16(6):529-38. PubMed ID: 11132900
[TBL] [Abstract][Full Text] [Related]
18. Subconjunctival sodium hyaluronate 2.3% in trabeculectomy: a prospective randomized clinical trial.
Lopes JF; Moster MR; Wilson RP; Altangerel U; Alvim HS; Tong MG; Fontanarosa J; Steinmann WC
Ophthalmology; 2006 May; 113(5):756-60. PubMed ID: 16650669
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
20. Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study.
Kandarakis S; Kontaxakis A; Doumazos L; Petrou P; Droutsas K; Papaconstantinou D; Georgalas I
Cutan Ocul Toxicol; 2022 Mar; 41(1):25-32. PubMed ID: 34749555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
